When does Nplate’s patent expire?
“Nplate” (romiplostim) is protected by multiple patents that expire on different dates, depending on the specific country and patent family. Public patent-watch resources typically show several relevant expirations rather than one single date.
Because you didn’t specify a country, the expiration date can’t be stated accurately in a single line. If you tell me the country (for example, US, EU/UK, or Japan), I can narrow it to the most likely controlling patents for Nplate in that jurisdiction.
Which patents usually control when a drug like Nplate faces generic or biosimilar competition?
For biologic drugs such as romiplostim, market entry by biosimilars (rather than standard generics) is often constrained by a mix of protections, including:
- Composition/use patents on the active substance.
- Formulation/device or manufacturing process patents.
- Patents on specific therapeutic uses or dosing regimens.
- Exclusivity periods granted by regulators (which are separate from patent expiry).
This means the “first possible” entry date may be later than the earliest patent expiry, depending on which protections are still active.
How do biosimilar timelines relate to patent expiration for Nplate?
Even after patent expiry, biosimilars may not launch immediately if:
- Other patents are still in force (or litigation stays entry).
- Regulatory approval can be granted, but commercial launch timing is delayed by enforcement actions or contract terms.
- Additional exclusivity or data-protection rules apply in the relevant jurisdiction.
So the key date is not always the earliest listed patent expiry.
What happens if a patent expires but lawsuits are ongoing?
If patent infringement suits or validity challenges are ongoing, courts can restrict launch even if some patents expire. In practice, this can delay biosimilar entry until litigation concludes or protections fully clear.
What information do I need to give a specific expiration date?
To provide an exact expiration timeline for Nplate, I need:
1) Country/region (US, EU, UK, etc.)
2) Whether you care about biosimilar entry timing or a specific patent’s expiry date
3) If you have a patent number (or a patent-watch link), I can map it to the correct expiry
If you reply with the country (and optionally your target patent or region), I’ll give the specific expiration date(s) and how they affect the likely entry window.
Sources
I can’t cite specific Nplate patent expiry dates from the provided information because none was included in your message. If you share a link to a patent record (or tell me the jurisdiction), I’ll produce a cited answer using that material.